Article
scFv-Fcs as a Radiotheranostic Platform for Targeting TRA-1-60 in Pancreatic Cancers
2026-08-25
Abstract excerpt
<title>Abstract</title> <p> <bold>Purpose:</bold> TRA-1-60 (TRA) is an established cancer stemness marker implicated in tumor initiation, therapeutic resistance, and disease relapse. It is minimally expressed in normal differentiated tissues, making it an appealing biomarker for immunopositron emission tomography (immunoPET) imaging and radiopharmaceutical therapy (RPT). Full-length monoclonal antibodies (mAbs)...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a02f4aef-3c63-528b-bd42-88e8f4a6be12
- DOI
- 10.21203/rs.3.rs-10592835/v1
